The functional effect of epigallocatechin gallate on ischemic stroke in rats

• Autorzy: Lim S.H. , Kim H. S. , Kim Y. K. , Kim T.-M. , Ima S. , Chung M. E. , Hong B. Y. , Ko Y. J. , Kim H. W. , Lee J. I.
• Języki publikacji: EN

Abstrakty

EN

We evaluated the efficacy of epigallocatechin gallate (EGCG) for improving function in rats with transient middle cerebral artery occlusion (MCAO). Three procedures underwent for each groups; MCAO and EGCG treatment, MCAO without treatment (MCAO control), and sham operation. Function was evaluated on days 1, 5, 10, and 14 after ischemia, using a modified sticky-tape test and the percentage weight borne on the paretic leg. Infarct volume did not differ between the EGCG-treated and MCAO control groups. Compared with the MCAO control group, the EGCG-treated group showed improved forelimb function and had normal function by day 10 (P<0.05). The improvements persisted until day 14 post-ischemia. In contrast, hind limb function did not differ between the EGCG-treated and MCAO control groups. Thus, EGCG improved certain aspects of function of forelimb until day 14 after MCAO in rats.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2010
• Tom: 70
• Numer: 1
• Opis fizyczny: p.40-46,fig.,ref.

Twórcy

autor

Lim S.H.

• Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

autor

Kim H. S.

• Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

autor

Kim Y. K.

• Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

autor

Kim T.-M.

• Center for Biomedical Informatics, Harvard Medical School, Boston, MA, USA

autor

Ima S.

• Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

autor

Chung M. E.

• Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

autor

Hong B. Y.

• Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

autor

Ko Y. J.

• Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

autor

Kim H. W.

• Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

autor

Lee J. I.

• Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

Bibliografia

• Arab L, Liu W, Elashoff D (2009) Green and Black Tea Consumption and Risk of Stroke. A Meta-Analysis. Stroke 40: 1786-1792.
• Burckhardt IC, Gozal D, Dayyat E, Cheng Y, Li RC, Goldbart AD, Row BW (2008) Green tea catechin poly­phenols attenuate behavioral and oxidative responses to intermittent hypoxia. Am J Respir Crit Care Med 177: 1135-1141.
• Choi YB, Kim YI, Lee KS, Kim BS, Kim DJ (2004) Protective effect of epigallocatechin gallate on brain dam­age after transient middle cerebral artery occlusion in rats. Brain Res 1019: 47-54.
• Clark RK, Lee EV, Fish CJ, White RF, Price WJ, Jonak ZL, Feuerstein GZ, Barone FC (1993) Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res Bull 31: 565-572.
• Deng HM, Yin ST, Yan D, Tang ML, Li CC, Chen JT, Wang M, Ruan DY (2008) Effects of EGCG on voltage-gated sodium channels in primary cultures of rat hippocampal CA1 neurons. Toxicology 252: 1-8.
• Fraser ML, Mok GS, Lee AH (2007) Green tea and stroke prevention: emerging evidence. Complement Ther Med 15: 46-53.
• Gladstone DJ, Black SE, Hakim AM (2002) Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33: 2123-2136.
• Haque AM, Hashimoto M, Katakura M, Hara Y, Shido O (2008) Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. J Nutr Biochem 19: 619­626.
• Isayama K, Pitts LH, Nishimura MC (1991) Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke 22: 1394-1398.
• Komotar RJ, Kim GH, Sughrue ME, Otten ML, Rynkowski MA, Kellner CP, Hahn DK, Merkow MB, Garrett MC, Starke RM, Connolly ES (2007) Neurologic assessment of somatosensory dysfunction following an experimental rodent model of cerebral ischemia. Nat Protoc 2: 2345-2347.
• Lee JI, Kim HW, Rhee WI, Park JH, Lim SH, Im S, Ko YJ (2006) The beneficial effect of intravenous zoledronic acid therapy following an acute stroke in rats. Bone 39: 377-382.
• Lim SH, Lee JS, Lee JI, Im S, Ko YJ, Kim HW (2008) The quantitative assessment of functional impairment and its correlation to infarct volume in rats with transient middle cerebral artery occlusion. Brain Res 1230: 303-309.
• Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
• Lorenz M, Urban J, Engelhardt U, Baumann G, Stangl K, Stangl V (2009) Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved. Basic Res Cardiol 104: 100-110.
• Ma J, Zhao L, Nowak TS Jr. (2006) Selective, reversible occlusion of the middle cerebral artery in rats by an intraluminal approach. Optimized filament design and methodology. J Neurosci Methods 156: 76-83.
• Mandel S, Amit T, Reznichenko L, Weinreb O, Youdim MB (2006) Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurode­generative disorders. Mol Nutr Food Res 50: 229-234.
• Nagai K, Jiang MH, Hada J, Nagata T, Yajima Y, Yamamoto S, Nishizaki T (2002) (-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant. Brain Res 956: 319-22.
• Rahman RM, Nair SM, Helps SC, Shaw OM, Sims NR, Rosengren RJ, Appleton I (2005) (-)-Epigallocatechin gallate as an intervention for the acute treatment of cere­bral ischemia. Neurosci Lett 382: 227-230.
• Sughrue ME, Mocco J, Komotar RJ, Mehra A, D'Ambrosio AL, Grobelny BT, Penn DL, Connolly ES Jr. (2006) An improved test of neurological dysfunction following tran­sient focal cerebral ischemia in rats. J Neurosci Methods 151: 83-89.
• Sutherland BA, Rahman RM, Appleton I (2006) Mechanisms of action of green tea catechins, with a focus on ischemia- induced neurodegeneration. J Nutr Biochem 17: 291-306.
• Takami S, Imai T, Hasumura M, Cho YM, Onose J, Hirose M (2008) Evaluation of toxicity of green tea catechins with 90-day dietary administration to F344 rats. Food Chem Toxicol 46: 2224-2229.
• Tanabe N, Suzuki H, Aizawa Y, Seki N (2008) Consumption of green and roasted teas and the risk of stroke incidence: results from the Tokamachi-Nakasato cohort study in Japan. Int J Epidemiol 37: 1030­1040.
• Xie W, Ramakrishna N, Wieraszko A, Hwang YW (2008) Promotion of neuronal plasticity by (-)-epigallocatechin- 3-gallate. Neurochem Res 33: 776-783.
• Zhang B, Rusciano D, Osborne NN (2008) Orally adminis­tered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. Brain Res 1198: 141-152.
• Zhang Y, Jin Y, Behr MJ, Feustel PJ, Morrison JP, Kimelberg HK (2005) Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia. Exp Neurol 196: 41-46.
• Zhao LR, Spellman S, Kim J, Duan WM, McCarthy JB, Low WC (2005) Synthetic fibronectin peptide exerts neu- roprotective effects on transient focal brain ischemia in rats. Brain Res 1054: 1-8.

Uwagi

PL

Rekord w opracowaniu